Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV

NA Halsey, JS Abramson, PJ Chesney… - …, 1998 - augusta.elsevierpure.com
Abstract The Food and Drug Administration recently approved the use of palivizumab (pale-
vizhumab), an intramuscularly administered monoclonal antibody preparation …

Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV

American Academy of Pediatrics Committee on … - Pediatrics, 1998 - cir.nii.ac.jp
抄録< jats: p> The Food and Drug Administration recently approved the use of palivizumab
(palē-vizhū-mäb), an intramuscularly administered monoclonal antibody preparation …

Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV

NA Halsey, JS Abramson, PJ Chesney… - …, 1998 - pure.johnshopkins.edu
Abstract The Food and Drug Administration recently approved the use of palivizumab (pale-
vizhumab), an intramuscularly administered monoclonal antibody preparation …